(Q45137202)

9 December 2017

In vitro antimicrobial activity of gatifloxacin compared with other quinolones against clinical isolates from cancer patients (English)

1 reference

9 December 2017

0 references

Kenneth V. I. Rolston

1

object named as

Kenneth V I Rolston

1 reference

9 December 2017

Irfan Vaziri

2

1 reference

9 December 2017

Susan Frisbee-Hume

3

1 reference

9 December 2017

Harriet Streeter

4

1 reference

9 December 2017

Barbara LeBlanc

5

1 reference

9 December 2017

26 October 2004

1 reference

9 December 2017

1 reference

9 December 2017

50

1 reference

9 December 2017

5

1 reference

9 December 2017

214-220

1 reference

Infection in cancer patients. A continuing association

9 December 2017

1 reference

The changing epidemiology of infections at cancer hospitals

21 January 2018

1 reference

Prophylaxis with fluoroquinolones for bacterial infections in neutropenic patients: a meta-analysis

21 January 2018

1 reference

Prospective randomized evaluation of ciprofloxacin versus piperacillin plus amikacin for empiric antibiotic therapy of febrile granulocytopenic cancer patients with lymphomas and solid tumors. The European Organization for Research on Treatment of C

21 January 2018

1 reference

Feasibility of outpatient management of fever in cancer patients with low-risk neutropenia: results of a prospective randomized trial

21 January 2018

1 reference

Susceptibilities of bacterial isolates from patients with cancer to levofloxacin and other quinolones

21 January 2018

1 reference

In-vitro activity of trovafloxacin against clinical bacterial isolates from patients with cancer.

21 January 2018

1 reference

In vitro antibacterial spectrum of a new broad-spectrum 8-methoxy fluoroquinolone, gatifloxacin

21 January 2018

1 reference

Antimicrobial activity of a novel des-fluoro (6) quinolone, garenoxacin (BMS-284756), compared to other quinolones, against clinical isolates from cancer patients

21 January 2018

1 reference

Emergence of fluoroquinolone-resistant Escherichia coli at a cancer center

21 January 2018

1 reference

Inhibitory activity on DNA gyrase and intracellular accumulation of quinolones: structure-activity relationship of Q-35 analogs.

21 January 2018

1 reference

DNA topoisomerase targets of the fluoroquinolones: a strategy for avoiding bacterial resistance

21 January 2018

1 reference

A fluoroquinolone antibiotic with a methoxy group at the 8 position yields reduced generation of 8-oxo-7,8-dihydro-2'-deoxyguanosine after ultraviolet-A irradiation.

21 January 2018

1 reference

Comparison of the in vitro activities of several new fluoroquinolones against respiratory pathogens and their abilities to select fluoroquinolone resistance.

21 January 2018

1 reference

In vitro activity of newer fluoroquinolones for respiratory tract infections and emerging patterns of antimicrobial resistance: data from the SENTRY antimicrobial surveillance program

21 January 2018

1 reference

BMS284756 (formerly T-3811, a des-fluoroquinolone) potency and spectrum tested against over 10,000 bacterial bloodstream infection isolates from the SENTRY antimicrobial surveillance programme (2000).

21 January 2018

1 reference

Salmonella spp. isolates causing bloodstream infections in Latin America: report of antimicrobial activity from the SENTRY Antimicrobial Surveillance Program (1997-2000).

21 January 2018

1 reference

Comparative in vitro activities of three new quinolones and azithromycin against aerobic pathogens causing respiratory tract and abdominal wound infections

21 January 2018

1 reference

Activities of newer quinolones against Escherichia coli and Klebsiella pneumoniae containing the plasmid-mediated quinolone resistance determinant qnr.

21 January 2018

1 reference

In vitro pharmacodynamic activity of gatifloxacin, gemifloxacin, moxifloxacin and levofloxacin against Streptococcus pneumoniae containing specific mutations in DNA gyrase and topoisomerase IV.

21 January 2018

1 reference

In vitro activity of gatifloxacin, compared with ciprofloxacin, clarithromycin, erythromycin, and rifampin, against Legionella species.

21 January 2018

1 reference

Comparative activities of ciprofloxacin, clinafloxacin, gatifloxacin, gemifloxacin, levofloxacin, moxifloxacin, and trovafloxacin against epidemiologically defined Acinetobacter baumannii strains

21 January 2018

1 reference

In vitro activity of moxifloxacin, levofloxacin, gatifloxacin and linezolid against Mycobacterium tuberculosis

21 January 2018

1 reference

In vitro activity of 11 antimicrobial agents, including gatifloxacin and GAR936, tested against clinical isolates of Mycobacterium marinum

21 January 2018

1 reference

In vitro activities of fluoroquinolones against the spirochete Borrelia burgdorferi

21 January 2018

1 reference

Comparative in vitro activity of gatifloxacin against Stenotrophomonas maltophilia and Burkholderia species isolates including evaluation of disk diffusion and E test methods.

21 January 2018

1 reference

2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer

21 January 2018

1 reference

Antimicrobial activity of gatifloxacin compared to seven other compounds tested against gram-positive organisms isolated at 10 cancer-treatment centers

21 January 2018

1 reference

Synergic activity of cephalosporins plus fluoroquinolones against Pseudomonas aeruginosa with resistance to one or both drugs

21 January 2018

1 reference

In vitro Synergy Studies Using Aztreonam and Fluoroquinolone Combinations against Six Species of Gram-Negative Bacilli

21 January 2018

1 reference

Contemporary in vitro synergy rates for aztreonam combined with newer fluoroquinolones and β-lactams tested against gram-negative bacilli

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000081708

1 reference

release_vs2r5nhsrrfzripcjdcfbgrie4

9 December 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/vs2r5nhsrrfzripcjdcfbgrie4

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference